These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 666466)

  • 21. [Digoxin: continuous or discontinuous treatment?].
    Gnocchi CA; Mazzocchi O; Yaryour C; Khoury MC; Noel ME; Torn A; Risso JA
    Medicina (B Aires); 1998; 58(3):271-6. PubMed ID: 9713095
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Interaction of amiodarone and digoxin].
    Nager G; Nager F
    Schweiz Med Wochenschr; 1983 Nov; 113(46):1727-30. PubMed ID: 6658416
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Prospective examinations of digitalis poisoning].
    Storstein L
    Fortschr Med; 1981 Aug; 99(31-32):1247-54. PubMed ID: 7274939
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparison between the effects of diltiazem and isosorbide dinitrate on digoxin pharmacodynamics and kinetics in the treatment of patients with chronic ischemic heart failure.
    Mahgoub AA; El-Medany AH; Abdulatif AS
    Saudi Med J; 2002 Jun; 23(6):725-31. PubMed ID: 12070557
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nicardipine does not significantly affect serum digoxin concentrations at the steady state of patients with congestive heart failure.
    Debruyne D; Commeau P; Grollier G; Huret B; Scanu P; Moulin M
    Int J Clin Pharmacol Res; 1989; 9(1):15-9. PubMed ID: 2707921
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Urinary excretion of reduced metabolites of digoxin.
    Lindenbaum J; Tse-Eng D; Butler VP; Rund DG
    Am J Med; 1981 Jul; 71(1):67-74. PubMed ID: 7246583
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interpretation of serum digoxin values in renal failure.
    Gault H; Vasdev S; Vlasses P; Longerich L; Dawe M
    Clin Pharmacol Ther; 1986 May; 39(5):530-6. PubMed ID: 3698461
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The clinical value of digoxin in patients with heart failure and sinus rhythm.
    McHaffie D; Purcell H; Mitchell-Heggs P; Guz A
    Q J Med; 1978 Oct; 47(188):401-19. PubMed ID: 751085
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cross reactivity of the EMIT digoxin assay with digoxin metabolites, and validation of the method for measurement of urinary digoxin.
    Linday L; Drayer DE
    Clin Chem; 1983 Jan; 29(1):175-7. PubMed ID: 6336678
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evidence for presence of a reduced form of digoxin-like immunoreactive factor (dihydro-DLIF) in mammalian tissues.
    Qazzaz HM; Jortani SA; Poole JM; Valdes R
    Clin Chem; 1996 Jul; 42(7):1092-9. PubMed ID: 8674194
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolism of digoxin after oral and intrajejunal administration.
    Magnusson JO
    Br J Clin Pharmacol; 1983 Dec; 16(6):741-2. PubMed ID: 6661363
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of the pharmacokinetics of digoxin and dihydrodigoxin in cats in single-dose studies.
    Heinz N; Flasch H
    Naunyn Schmiedebergs Arch Pharmacol; 1978 Jun; 303(2):181-7. PubMed ID: 673023
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biotransformation and elimination of digoxin with normal and minimal renal function.
    Gault MH; Sugden D; Maloney C; Ahmed M; Tweeddale M
    Clin Pharmacol Ther; 1979 May; 25(5 Pt 1):499-513. PubMed ID: 436354
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Decreased digoxin cardioinactive-reduced metabolites after administration as an encapsulated liquid concentrate.
    Rund DG; Lindenbaum J; Dobkin JF; Butler VP; Saha JR
    Clin Pharmacol Ther; 1983 Dec; 34(6):738-43. PubMed ID: 6641088
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased metabolism to dihydrodigoxin after intake of a microencapsulated formulation of digoxin.
    Magnusson JO; Bergdahl B; Bogentoft C; Gustafsson S; Jonsson UE
    Eur J Clin Pharmacol; 1984; 27(2):197-202. PubMed ID: 6499898
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reduction of digoxin to 20R-dihydrodigoxin by cultures of Eubacterium lentum.
    Robertson LW; Chandrasekaran A; Reuning RH; Hui J; Rawal BD
    Appl Environ Microbiol; 1986 Jun; 51(6):1300-3. PubMed ID: 3729400
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Determination of tritiated digoxin and metabolites in urine by liquid chromatography.
    Eriksson BM; Tekenbergs L; Magnusson JO; Molin L
    J Chromatogr; 1981 May; 223(2):401-8. PubMed ID: 7251795
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Digoxin disposition in elderly humans with hypochlorhydria.
    Hui J; Geraets DR; Chandrasekaran A; Wang YM; Caldwell JH; Robertson LW; Donnerberg RL; Reuning RH
    J Clin Pharmacol; 1994 Jul; 34(7):734-41. PubMed ID: 7929867
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lack of difference in digoxin urinary excretion with two intravenous infusion rates.
    Lindenbaum J; Long R; Wenger T; Mallis G; Cato A
    Clin Pharmacol Ther; 1981 Sep; 30(3):317-20. PubMed ID: 7273595
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bioavailability assessment: methods to estimate total area (AUC O to infinity) and total amount excreted (A infinity e) and importance of blood and urine sampling scheme with application to digoxin.
    Wagner JG; Ayres JW
    J Pharmacokinet Biopharm; 1977 Oct; 5(5):533-57. PubMed ID: 925886
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.